1. Overview of medicine and food homologous enterprises
Medicine and food homologous enterprises refer to enterprises that use Chinese medicinal materials as the main raw materials and process them into various food and health care products through modern production technology. The products of medicine and food homology enterprises not only have the taste and nutritional value of food, but also have the health care and effect of traditional Chinese medicine. However, with the intensification of market competition and the continuous change of consumer demand, medicine and food homologous enterprises are facing many bottlenecks in their development.
Second, the top ten development bottlenecks that medicine and food homologous enterprises need to break through
1.The quality of raw materials is unstable
The products of medicinal and edible homologous enterprises use Chinese herbal medicines as the main raw materials, however, due to the influence of factors such as the origin, variety, and harvest season of Chinese herbal medicines, the quality of raw materials is unstable. This will not only affect the quality and taste of the product, but also the health effect and safety of the product. Therefore, pharmaceutical and edible homologous enterprises need to establish a stable raw material channel and strengthen the control and management of raw material quality.
2.The production process is backward
Although some progress has been made in the homologous enterprises of medicine and food, there are still some enterprises whose production processes are relatively backward, resulting in poor product quality and taste, and unable to meet the needs of consumers. Therefore, enterprises need to continuously improve the production process to improve the quality and taste of the product.
3.Brand awareness is not strong
Many medicine and food homologous enterprises lack brand awareness, only pay attention to the production and sales of products, and ignore the brand building and maintenance. This will not only affect the image and credibility of the enterprise, but also affect the market competitiveness of the product. Therefore, enterprises need to strengthen brand building and improve brand awareness and reputation.
4.Lack of professionals
Medicinal and edible homologous enterprises need to have professional R&D, production, sales and management talents, but at present, many enterprises lack talents in these aspects, resulting in insufficient product research and development capabilities, backward production processes, poor sales channels and other problems. Therefore, enterprises need to strengthen the introduction and training of talents and improve the comprehensive strength of enterprises.
5.Food safety issues
The products of medicine and food homologous enterprises involve food safety issues, and if the product quality is not up to standard or there are potential safety hazards, it will bring a threat to the health of consumers. Therefore, enterprises need to strengthen product quality control and safety management to ensure the safety and reliability of products.
6.Lack of innovation and differentiation competitiveness
With the intensification of market competition, pharmaceutical and food homologous enterprises need to continuously improve their innovation capabilities and differentiated competitiveness to avoid homogeneous competition and war. However, many enterprises lack a sense of innovation and differentiated competition strategies, resulting in a lack of characteristics and competitiveness of products. Therefore, enterprises need to strengthen R&D and innovation, and develop new products and services with characteristics.
7.Poor sales channels
The products of medicine and food homologous enterprises need to enter the market and be accepted by consumers, but the sales channels of many enterprises are not smooth, resulting in the products being unable to effectively enter the market and be recognized by consumers. Therefore, enterprises need to strengthen the construction and maintenance of sales channels to improve the market coverage and awareness of products.
8.Lack of cooperation and alliance
Pharmaceutical and food homologous enterprises can achieve resource sharing and complementary advantages through cooperation and alliances, so as to improve the competitiveness and market share of enterprises. However, many enterprises lack a sense of cooperation and alliance, resulting in the inability to effectively integrate resources and develop and grow. Therefore, enterprises need to strengthen the sense of cooperation and alliance, actively look for partners, realize resource sharing and complementary advantages, improve the competitiveness and market share of enterprises, and achieve win-win development. For example, the joint exchange of medicine and food homology ** chain platform is a good platform dedicated to the operation and incubation of China's medicine and food homology brand
9.Laws and regulations are not perfect
However, at present, the relevant laws and regulations are not perfect, which cannot effectively protect the legitimate rights and interests of enterprises, nor can they standardize the business behavior of enterprises, which brings certain uncertainties and risks to the development of enterprises.
10.The pressure on environmental protection is increasing
With the continuous improvement of environmental awareness and strict supervision of policies, medicine and food homologous enterprises are facing increasing environmental protection pressure, and some enterprises with high pollution and high energy consumption are facing the pressure of rectification or closure, so enterprises need to strengthen the construction of environmental awareness and environmental protection measures, actively promote cleaner production and energy conservation and emission reduction, reduce environmental pollution and resource consumption, and achieve sustainable development.
How to break through, welcome to pay attention to the next sharing.